Mutations in Nrg3 have recently been reported to increase the risk for schizophrenia, and to alter activation of the PFC in humans (Kao et al., 2010; Gupta et al., 2011; Tost et al., 2014). This evidence concerns the gene NRG3 and schizophrenia.